Article
A clonal expression biomarker associates with lung cancer mortality
1 Oct 2019
Abstract excerpt
An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes predictive of outcome, improving diagnostic precision beyond clinical descriptors such as tumor stage1. Transcriptomic intratumor heterogeneity (RNA-ITH) has been shown to confound existing expression-based biomarkers across multiple cancer types2–6. Here, we analyze multi-region whole-exome and RNA sequencing data for 156...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
